Ilypsa
Biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
Launch date
Employees
Market cap
-
Enterprise valuation
$420m (Public information from Jun 2007)
Santa Clara United States (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$8.0m | Series A | ||
$36.0m | Series B | ||
$420m Valuation: $420m | Acquisition | ||
| Total Funding | $44.0m | ||